How respiratory virus vaccines protect people in Cleveland across health and social backgrounds
RFA-IP-22-004, CORVETS - Cleveland Ohio Respiratory Viruses Vaccines Effectiveness across Traditional Risk Factors and Social Determinants of Health
This project is looking at how well flu, COVID-19, and other respiratory virus vaccines keep children and adults from getting sick when they visit outpatient clinics in Cleveland.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University Hospitals of Cleveland NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11423354 on NIH RePORTER |
What this research studies
If you join, the team will enroll you when you go to an outpatient clinic with symptoms of an acute respiratory infection and add your de-identified health information to a study repository. They plan to enroll at least 1,000 patients each year from University Hospitals, Case Western Reserve, and the Cleveland VA to create a racially and socially diverse sample. Researchers will collect respiratory samples and use molecular testing and viral genome sequencing to identify the specific viruses and variants causing illness. They will link those lab results to your vaccination history, medical risk factors, and household or community social factors to see how protection varies across people.
Who could benefit from this research
Good fit: Ideal candidates are children and adults in the Cleveland area who seek outpatient care for flu-like or COVID-like symptoms, including patients at University Hospitals, affiliated clinics, and the Cleveland VA.
Not a fit: People without symptoms, those hospitalized for severe respiratory illness, or individuals living outside the study's Cleveland-area clinics are unlikely to participate or directly benefit.
Why it matters
Potential benefit: Findings could help tailor vaccine recommendations and outreach so people and communities at higher risk get better protection.
How similar studies have performed: Similar vaccine-effectiveness networks using test-negative designs and genomic sequencing have successfully tracked vaccine performance and variant impacts, so this approach builds on proven methods.
Where this research is happening
Cleveland, United States
- University Hospitals of Cleveland — Cleveland, United States (Active)
Researchers
- Principal investigator: Saade, Elie — University Hospitals of Cleveland
- Study coordinator: Saade, Elie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.